Table 2. Correlations of the 8 lncRNAs and the lncRNA signature risk score with clinical features in BC patients (presented as P value).

ID	Menopause (Indeterminate VS Peri VS Post VS Pre)	Tumor Status (Tumor free VS With tumor)	Age (<65 VS. ≥65)	Surgical(Lumpectomy VS Modified Radical Mastectomy VS Other VS Simple Mastectomy)	T (T1 vs T2 VS T3 VS T4)	N (N0 vs N1 VS N2 VS N3 VS Nx)	M (M0 VS M1 VS Mx)	Stage (I VS. II VS. III VS IV)
MNX1-AS1	0.001	1.000	0.125	0.955	0.001	0.131	0.765	0.008
SIRLNT	0.357	0.687	0.539	0.003	0.376	0.280	0.473	0.155
AC092920.1	0.941	0.348	0.046	0.272	0.020	0.433	0.355	0.040
AC105219.1	0.467	0.081	0.759	0.313	0.405	0.149	0.004	0.032
AL355312.3	0.158	0.081	0.539	0.164	0.982	0.447	0.743	0.905
AC055854.1	0.204	0.023	0.220	0.029	0.178	0.156	0.154	0.080
LINC01117	0.988	0.893	0.759	0.033	0.103	0.373	0.816	0.868
ACTA2-AS1	0.084	0.502	<0.001	0.002	0.002	0.211	0.012	0.031
riskScore	<0.001	0.023	0.066	0.045	0.001	0.110	0.124	0.052